Robert D. Pesek
Professor
Also affiliated: Cincinnati Children's Hospital Medical Center (2024–2025); Arkansas Children's Hospital (2013–2026); Children's Hospital of Philadelphia (2024); Baylor College of Medicine (2023); Medical College of Wisconsin (2024); University of Arkansas Medical Center (2026); Texas Children's Hospital (2023); Arkansas Children's Research Institute (2024–2026); University of Cincinnati (2024–2025); University of Pennsylvania (2024); Icahn School of Medicine at Mount Sinai (2024)
Peds Pediatrics, College of Medicine
Research Areas
Biomedical Subjects
Biography and Research Information
OverviewAI-generated summary
Robert D. Pesek, MD, is an Assistant Professor in the Department of Pediatrics at the University of Arkansas for Medical Sciences (UAMS) and practices at Arkansas Children's Hospital. He also serves as the medical director for the Allergy and Eosinophilic Gastrointestinal Disorders Clinics at Arkansas Children's Hospital. Dr. Pesek's research focuses on primary immunodeficiency, food allergies, and eosinophilic gastrointestinal disorders. His work includes investigating novel baseline predictors of adverse events during oral immunotherapy in children with peanut allergy and the safety of epicutaneous immunotherapy for peanut allergy treatment.
Dr. Pesek has contributed to the development of consensus recommendations for eosinophilic gastrointestinal disease nomenclature and clinical severity indices for eosinophilic esophagitis. His publications also address increasing rates of diagnosis, co-occurrence, and treatment patterns of eosinophilic gastritis, gastroenteritis, and colitis, as well as the association between endoscopic and histologic findings in non-esophageal eosinophilic gastrointestinal disorders. He has a publication record including research on Dupilumab for eosinophilic esophagitis in young children.
He holds an h-index of 20, with over 1,486 citations across his 72 publications. Dr. Pesek collaborates with several faculty members at UAMS, including Akilah A. Jefferson, Erhan Ararat, Amy M. Scurlock, and Stacie M. Jones. He leads a research group within his department.
Research Overview
Robbie Pesek, MD, is an Assistant Professor of Allergy and Immunology for the University of Arkansas forMedical Sciences (UAMS) and Arkansas Children's Hospital. He is also the medical director for the Allergy and Eosinophilic Gastrointestinal Disorders Clinics at ACH. Dr. Pesek received his Bachelor of Science from the University of Arkansas at Fayetteville and completed his medical degree at UAMS. He completed his Pediatric residency at ACH and training in Allergy/Immunology at the University of South Florida in Tampa, Florida. He joined the faculty at ACH in 2011. Dr. Pesek is a member of the Arkansas Medical Society, American Academy of Pediatrics, American College of Allergy, Asthma, and Immunology, and the American Academy of Allergy, Asthma, and Immunology. His current research interests include primary immunodeficiency, food allergies, and eosinophilic gastrointestinal disorders. Some of the UAMS College of Medicine faculty members provide pediatric patient care at Arkansas Children's Hospital. In addition, a wide range of pediatric services are provided in more than 35 subspecialties around Arkansas in locations such as the Schmieding Developmental Center in Springdale and the James L. Dennis Developmental Center in Little Rock. To make an appointment at Arkansas Children's Hospital, please call 501-364-4000.
Metrics
- h-index: 20
- Publications: 72
- Citations: 1,493
Positions
-
Professor publications 2013–2026University of Arkansas for Medical Sciences Peds Pediatrics, College of Medicine Institutional directory
Selected Publications
-
Early-life peanut oral immunotherapy associated with long-term ingestion and immunologic changes (2026)
-
Implementation of early peanut introduction among providers in a southern US state (2026)
-
Epitope-Specific Antibody Trajectories and Early Peanut OIT Outcomes in Toddlers (2026)
-
Machine Learning Models Using Epitope-Specific Antibodies Predict Desensitization and Remission in Early Peanut Oral Immunotherapy (2026)
-
Patient-Reported Outcome Scores Are Comparable in Multiregional Versus Uniregional Eosinophilic Esophagitis (2025)
-
Current Practices Among 13 Severe Pediatric Asthma Programs in the United States (2025)
-
Epinephrine Prescription and Post-injection Monitoring Practices for Biologic Therapies in Pediatric Severe Asthma Clinics: A Multicenter Survey Analysis (2025)
-
Video directly observed therapy to improve inhaler technique among pediatric patients with persistent asthma (2025)
-
Multidisciplinary care in pediatric severe asthma: A comparative outcomes analysis (2025)
-
Rare inborn error of immunity presenting as acute respiratory failure (2024)
-
S661 Dupilumab Improves Multiple Histopathologic Endpoints in Children With Eosinophilic Esophagitis: 52-Week Results From the Phase 3 EoE KIDS Trial (2024)
-
Effects of nonpharmaceutical interventions during COVID-19 pandemic on pediatric asthma exacerbations and viral infections (2024)
-
Advances and ongoing challenges in eosinophilic gastrointestinal disorders presented at the CEGIR/TIGERs Symposium at the 2024 American Academy of Allergy, Asthma & Immunology meeting (2024)
-
Long-term durability between parent and child patient-reported outcomes in eosinophilic esophagitis (2024)
-
A Rare Condition Masquerading as a Common Disease (2024)
Grants & Funding
As listed on this researcher's institutional profile.
- Eosinopilic Research Training UAMS ACHRI Flow Through Principal Investigator
Collaboration Network
Top Collaborators
- International Consensus Recommendations for Eosinophilic Gastrointestinal Disease Nomenclature
- Increasing Rates of Diagnosis, Substantial Co-Occurrence, and Variable Treatment Patterns of Eosinophilic Gastritis, Gastroenteritis, and Colitis Based on 10-Year Data Across a Multicenter Consortium
- A Clinical Severity Index for Eosinophilic Esophagitis: Development, Consensus, and Future Directions
- Development of a core outcome set for therapeutic studies in eosinophilic esophagitis (COREOS)
- Association Between Endoscopic and Histologic Findings in a Multicenter Retrospective Cohort of Patients with Non-esophageal Eosinophilic Gastrointestinal Disorders
Showing 5 of 12 shared publications
- Increasing Rates of Diagnosis, Substantial Co-Occurrence, and Variable Treatment Patterns of Eosinophilic Gastritis, Gastroenteritis, and Colitis Based on 10-Year Data Across a Multicenter Consortium
- A Clinical Severity Index for Eosinophilic Esophagitis: Development, Consensus, and Future Directions
- Development of a core outcome set for therapeutic studies in eosinophilic esophagitis (COREOS)
- Association Between Endoscopic and Histologic Findings in a Multicenter Retrospective Cohort of Patients with Non-esophageal Eosinophilic Gastrointestinal Disorders
- Future therapies for eosinophilic gastrointestinal disorders
Showing 5 of 10 shared publications
- Increasing Rates of Diagnosis, Substantial Co-Occurrence, and Variable Treatment Patterns of Eosinophilic Gastritis, Gastroenteritis, and Colitis Based on 10-Year Data Across a Multicenter Consortium
- A Clinical Severity Index for Eosinophilic Esophagitis: Development, Consensus, and Future Directions
- Association Between Endoscopic and Histologic Findings in a Multicenter Retrospective Cohort of Patients with Non-esophageal Eosinophilic Gastrointestinal Disorders
- Increasing Rates of Diagnosis, Substantial Co-occurrence, and Variable Treatment Patterns of Eosinophilic Gastritis, Gastroenteritis and Colitis Based on 10 Year Data Across a Multi-Center Consortium
- A Clinical Severity Index for Eosinophilic Esophagitis: Development, Consensus, and Future Directions
Showing 5 of 10 shared publications
- Increasing Rates of Diagnosis, Substantial Co-Occurrence, and Variable Treatment Patterns of Eosinophilic Gastritis, Gastroenteritis, and Colitis Based on 10-Year Data Across a Multicenter Consortium
- Development of a core outcome set for therapeutic studies in eosinophilic esophagitis (COREOS)
- Association Between Endoscopic and Histologic Findings in a Multicenter Retrospective Cohort of Patients with Non-esophageal Eosinophilic Gastrointestinal Disorders
- Eosinophilic gastrointestinal disease below the belt
- Increasing Rates of Diagnosis, Substantial Co-occurrence, and Variable Treatment Patterns of Eosinophilic Gastritis, Gastroenteritis and Colitis Based on 10 Year Data Across a Multi-Center Consortium
Showing 5 of 9 shared publications
- International Consensus Recommendations for Eosinophilic Gastrointestinal Disease Nomenclature
- A Clinical Severity Index for Eosinophilic Esophagitis: Development, Consensus, and Future Directions
- Development of a core outcome set for therapeutic studies in eosinophilic esophagitis (COREOS)
- Association Between Endoscopic and Histologic Findings in a Multicenter Retrospective Cohort of Patients with Non-esophageal Eosinophilic Gastrointestinal Disorders
- A Clinical Severity Index for Eosinophilic Esophagitis: Development, Consensus, and Future Directions
Showing 5 of 9 shared publications
- International Consensus Recommendations for Eosinophilic Gastrointestinal Disease Nomenclature
- Increasing Rates of Diagnosis, Substantial Co-Occurrence, and Variable Treatment Patterns of Eosinophilic Gastritis, Gastroenteritis, and Colitis Based on 10-Year Data Across a Multicenter Consortium
- A Clinical Severity Index for Eosinophilic Esophagitis: Development, Consensus, and Future Directions
- Association Between Endoscopic and Histologic Findings in a Multicenter Retrospective Cohort of Patients with Non-esophageal Eosinophilic Gastrointestinal Disorders
- Increasing Rates of Diagnosis, Substantial Co-occurrence, and Variable Treatment Patterns of Eosinophilic Gastritis, Gastroenteritis and Colitis Based on 10 Year Data Across a Multi-Center Consortium
Showing 5 of 8 shared publications
- International Consensus Recommendations for Eosinophilic Gastrointestinal Disease Nomenclature
- Increasing Rates of Diagnosis, Substantial Co-Occurrence, and Variable Treatment Patterns of Eosinophilic Gastritis, Gastroenteritis, and Colitis Based on 10-Year Data Across a Multicenter Consortium
- A Clinical Severity Index for Eosinophilic Esophagitis: Development, Consensus, and Future Directions
- Association Between Endoscopic and Histologic Findings in a Multicenter Retrospective Cohort of Patients with Non-esophageal Eosinophilic Gastrointestinal Disorders
- Increasing Rates of Diagnosis, Substantial Co-occurrence, and Variable Treatment Patterns of Eosinophilic Gastritis, Gastroenteritis and Colitis Based on 10 Year Data Across a Multi-Center Consortium
Showing 5 of 8 shared publications
- International Consensus Recommendations for Eosinophilic Gastrointestinal Disease Nomenclature
- A Clinical Severity Index for Eosinophilic Esophagitis: Development, Consensus, and Future Directions
- Development of a core outcome set for therapeutic studies in eosinophilic esophagitis (COREOS)
- A Clinical Severity Index for Eosinophilic Esophagitis: Development, Consensus, and Future Directions
- Advances and ongoing challenges in eosinophilic gastrointestinal disorders presented at the CEGIR/TIGERs Symposium at the 2024 American Academy of Allergy, Asthma & Immunology meeting
Showing 5 of 8 shared publications
- Novel baseline predictors of adverse events during oral immunotherapy in children with peanut allergy
- Safety of epicutaneous immunotherapy for the treatment of peanut allergy: A phase 1 study using the Viaskin patch
- Distinct trajectories distinguish antigen-specific T cells in peanut-allergic individuals undergoing oral immunotherapy
- Effects of allergen sensitization on response to therapy in children with eosinophilic esophagitis
- Food insecurity and allergic diseases: A call to collective action
Showing 5 of 7 shared publications
- Novel baseline predictors of adverse events during oral immunotherapy in children with peanut allergy
- Effects of allergen sensitization on response to therapy in children with eosinophilic esophagitis
- Food insecurity and allergic diseases: A call to collective action
- Effects of nonpharmaceutical interventions during COVID-19 pandemic on pediatric asthma exacerbations and viral infections
- Multidisciplinary care in pediatric severe asthma: A comparative outcomes analysis
Showing 5 of 6 shared publications
- Increasing Rates of Diagnosis, Substantial Co-Occurrence, and Variable Treatment Patterns of Eosinophilic Gastritis, Gastroenteritis, and Colitis Based on 10-Year Data Across a Multicenter Consortium
- A Clinical Severity Index for Eosinophilic Esophagitis: Development, Consensus, and Future Directions
- Association Between Endoscopic and Histologic Findings in a Multicenter Retrospective Cohort of Patients with Non-esophageal Eosinophilic Gastrointestinal Disorders
- Increasing Rates of Diagnosis, Substantial Co-occurrence, and Variable Treatment Patterns of Eosinophilic Gastritis, Gastroenteritis and Colitis Based on 10 Year Data Across a Multi-Center Consortium
- A Clinical Severity Index for Eosinophilic Esophagitis: Development, Consensus, and Future Directions
Showing 5 of 6 shared publications
- Increasing Rates of Diagnosis, Substantial Co-Occurrence, and Variable Treatment Patterns of Eosinophilic Gastritis, Gastroenteritis, and Colitis Based on 10-Year Data Across a Multicenter Consortium
- Development of a core outcome set for therapeutic studies in eosinophilic esophagitis (COREOS)
- Association Between Endoscopic and Histologic Findings in a Multicenter Retrospective Cohort of Patients with Non-esophageal Eosinophilic Gastrointestinal Disorders
- Increasing Rates of Diagnosis, Substantial Co-occurrence, and Variable Treatment Patterns of Eosinophilic Gastritis, Gastroenteritis and Colitis Based on 10 Year Data Across a Multi-Center Consortium
- Long-term durability between parent and child patient-reported outcomes in eosinophilic esophagitis
Showing 5 of 6 shared publications
- A Clinical Severity Index for Eosinophilic Esophagitis: Development, Consensus, and Future Directions
- Development of a core outcome set for therapeutic studies in eosinophilic esophagitis (COREOS)
- Association Between Endoscopic and Histologic Findings in a Multicenter Retrospective Cohort of Patients with Non-esophageal Eosinophilic Gastrointestinal Disorders
- A Clinical Severity Index for Eosinophilic Esophagitis: Development, Consensus, and Future Directions
- Dupilumab Improves Histologic And Endoscopic Outcomes In Children Aged 1 To <12 Years With Eosinophilic Esophagitis (EoE): 52-Week Results From The Phase 3 EoE KIDS Trial
Showing 5 of 6 shared publications
- A Clinical Severity Index for Eosinophilic Esophagitis: Development, Consensus, and Future Directions
- Development of a core outcome set for therapeutic studies in eosinophilic esophagitis (COREOS)
- A Clinical Severity Index for Eosinophilic Esophagitis: Development, Consensus, and Future Directions
- Breakthroughs in understanding and treating eosinophilic gastrointestinal diseases presented at the CEGIR/TIGERs Symposium at the 2022 American Academy of Allergy, Asthma & Immunology Meeting
- Long-term durability between parent and child patient-reported outcomes in eosinophilic esophagitis
Showing 5 of 6 shared publications
- Effects of allergen sensitization on response to therapy in children with eosinophilic esophagitis
- Effects of nonpharmaceutical interventions during COVID-19 pandemic on pediatric asthma exacerbations and viral infections
- Successful desensitization in a pediatric patient with acetazolamide allergy
- A Rare Condition Masquerading as a Common Disease
- Rare inborn error of immunity presenting as acute respiratory failure
Similar Researchers
Based on overlapping research topics